Drug profile

The FDA adverse-event record for Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, Modified Live Virus

Name: Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, Modified Live Virus - FDA Animal Adverse Event Reports
Creator: PlainBreed
License: https://creativecommons.org/publicdomain/zero/1.0/

40 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, Modified Live Virus. Species, reactions, and outcomes follow.

#1250 of 2,679
by report volume (all drugs): 40
adverse-event reports: 12.5%
death-coded share: Cat
most-reported species

Compiled by PlainBreed

Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, Modified Live Virus ranks #1245 of 2679 by total reports (40). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1): 97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1): #1245
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, Modified Live Virus has 40 reports now versus 40 in that prior snapshot: 0 the same number of (0.0%).

Report change: +0
Death-coded reports: +0
Death-coded share: +0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, Modified Live Virus changes

Signature read: death-coded share at 12.5% is the most distinctive stamp on Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, Modified Live Virus's FDA AER row.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

12.5%

Death-coded share of reports

Active Ingredients

Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, Modified Live Virus

Administration Routes

SubcutaneousNasalParenteral

Species Affected

Cat 40

Most Affected Breeds

Domestic Shorthair 27

Domestic Mediumhair 4

Cat (unknown) 3

Domestic Longhair 2

Persian 1

Siamese 1

Bombay 1

Eurasian Lynx 1

Most Reported Reactions

Vomiting 14

Anaphylaxis 7

Lethargy (see also Central nervous system depression in Neurological) 6

Weight loss 5

Behavioural disorder NOS 5

Diarrhoea 5

Lethargy (see also Central nervous system depression in 'Neurological') 5

Fever 4

Hypersalivation 4

Death 4

Ocular discharge 3

Hyperthermia 3

Outcome Breakdown

Recovered/Normal

17 (42.5%)

Outcome Unknown

11 (27.5%)

Ongoing

7 (17.5%)

Died

4 (10.0%)

Euthanized

1 (2.5%)

Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, Modified Live Virus Adverse Event Insights

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full drug directory to compare report counts across products. All drugs

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Feline Rhinotracheitis-Calici-Panleukopenia Vaccine, Modified Live Virus (#1250 of 2,679 by report volume); death-coded 12.5%. PlainBreed drug row · death-coded share stamp 12.5% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →